DongKook Pharmaceutical Return On Asset vs. Shares Owned By Insiders

086450 Stock  KRW 16,140  180.00  1.10%   
Taking into consideration DongKook Pharmaceutical's profitability measurements, DongKook Pharmaceutical Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess DongKook Pharmaceutical's ability to earn profits and add value for shareholders.
For DongKook Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DongKook Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DongKook Pharmaceutical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DongKook Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DongKook Pharmaceutical Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between DongKook Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if DongKook Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DongKook Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

DongKook Pharmaceutical Shares Owned By Insiders vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining DongKook Pharmaceutical's current stock value. Our valuation model uses many indicators to compare DongKook Pharmaceutical value to that of its competitors to determine the firm's financial worth.
JavaScript chart by amCharts 3.21.15058470086900086450 01020304050 -0.0500.050.100.15
DongKook Pharmaceutical Co is number one stock in return on asset category among its peers. It also is number one stock in shares owned by insiders category among its peers making about  766.45  of Shares Owned By Insiders per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value DongKook Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for DongKook Pharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

DongKook Shares Owned By Insiders vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

DongKook Pharmaceutical

Return On Asset

 = 

Net Income

Total Assets

 = 
0.0608
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

DongKook Pharmaceutical

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
46.60 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

DongKook Shares Owned By Insiders Comparison

DongKook Pharmaceutical is currently under evaluation in shares owned by insiders category among its peers.

DongKook Pharmaceutical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in DongKook Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, DongKook Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of DongKook Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of DongKook Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea. DongKook Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.

DongKook Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on DongKook Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of DongKook Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the DongKook Pharmaceutical's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in DongKook Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Use Investing Themes to Complement your DongKook Pharmaceutical position

In addition to having DongKook Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Asset Management Thematic Idea Now

Asset Management
Asset Management Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Asset Management theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Asset Management Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in DongKook Stock

To fully project DongKook Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of DongKook Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include DongKook Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.
Potential DongKook Pharmaceutical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although DongKook Pharmaceutical investors may work on each financial statement separately, they are all related. The changes in DongKook Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on DongKook Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.